Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arno Velds

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Nature Immunology|August 23, 2012
Reassessing genomic targeting of AIDMarc A Hogenbirk, Arno Velds, Ron M Kerkhoven, et al.
NAR Cancer|November 5, 2025
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer modelsAdva Kochavi, Arno Velds, Maya Suzuki, et al.
Plos One|April 24, 2008
The T7-primer is a source of experimental bias and introduces variability between microarray platformsRon M Kerkhoven, Daoud Sie, Marja Nieuwland, et al.
BMC Research Notes|November 13, 2010
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH dataJorma J de Ronde, Christiaan Klijn, Arno Velds, et al.
Breast Cancer Research : BCR|October 31, 2006
Classification of ductal carcinoma in situ by gene expression profilingJuliane Hannemann, Arno Velds, Johannes B G Halfwerk, et al.
BMC Bioinformatics|April 4, 2016
Reproducibility of Illumina platform deep sequencing errors allows accurate determination of DNA barcodes in cellsJoost B Beltman, Jos Urbanus, Arno Velds, et al.
Anesthesia and Analgesia|October 5, 2010
Volatile anesthetics modulate gene expression in breast and brain tumor cellsJohannes M Huitink, Mike Heimerikxs, Marja Nieuwland, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2016
Defining chromosomal translocation risks in cancerMarc A Hogenbirk, Marinus R Heideman, Iris de Rink, et al.
Cancer Cell|June 15, 2004
Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancerRob Michalides, Alexander Griekspoor, Astrid Balkenende, et al.
Nature Chemical Biology|February 14, 2006
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitorsThijn R Brummelkamp, Armida W M Fabius, Jasper Mullenders, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Nature Immunology|August 23, 2012
Reassessing genomic targeting of AIDMarc A Hogenbirk, Arno Velds, Ron M Kerkhoven, et al.
NAR Cancer|November 5, 2025
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer modelsAdva Kochavi, Arno Velds, Maya Suzuki, et al.
Plos One|April 24, 2008
The T7-primer is a source of experimental bias and introduces variability between microarray platformsRon M Kerkhoven, Daoud Sie, Marja Nieuwland, et al.
BMC Research Notes|November 13, 2010
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH dataJorma J de Ronde, Christiaan Klijn, Arno Velds, et al.
Breast Cancer Research : BCR|October 31, 2006
Classification of ductal carcinoma in situ by gene expression profilingJuliane Hannemann, Arno Velds, Johannes B G Halfwerk, et al.
BMC Bioinformatics|April 4, 2016
Reproducibility of Illumina platform deep sequencing errors allows accurate determination of DNA barcodes in cellsJoost B Beltman, Jos Urbanus, Arno Velds, et al.
Anesthesia and Analgesia|October 5, 2010
Volatile anesthetics modulate gene expression in breast and brain tumor cellsJohannes M Huitink, Mike Heimerikxs, Marja Nieuwland, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2016
Defining chromosomal translocation risks in cancerMarc A Hogenbirk, Marinus R Heideman, Iris de Rink, et al.
Cancer Cell|June 15, 2004
Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancerRob Michalides, Alexander Griekspoor, Astrid Balkenende, et al.
Nature Chemical Biology|February 14, 2006
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitorsThijn R Brummelkamp, Armida W M Fabius, Jasper Mullenders, et al.
Pageof 5